Who
Jason Paul Steik
Chief Clinical Officer
Company insider
Files Form 4 as: Chief Clinical Officer, The Pennant Group.
In numbers
- Trades disclosed
- 4
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $107K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 5 Mar 2026
- Last trade
- 6 Aug 2026
- Last filed
- 10 Aug 2026
Companies traded
Activity over time
1 Aug – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Aug 2026filed 10 Aug 2026 | PNTG The Pennant GroupProviders & Facilities | SEC FORM 4 Sold | $54K1,394 at $38.52 | filing |
| 6 Aug 2026filed 10 Aug 2026 | PNTG The Pennant GroupProviders & Facilities | SEC FORM 4 Sold | $54K1,394 at $38.52 | filing |
| 5 Mar 2026filed 12 Mar 2026 | PNTG The Pennant Groupoption or derivative · Providers & Facilities | SEC FORM 4 Code A | $866K26,000 at $33.30 | filing |
| 5 Mar 2026filed 12 Mar 2026 | PNTG The Pennant Groupoption or derivative · Providers & Facilities | SEC FORM 4 Code A | $866K26,000 at $33.30 | filing |
News
No headline names them, or the companies they trade most, lately.